KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Cost of Revenue: 2020-2025

Historic Cost of Revenue for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to $8.2 million.

  • Ginkgo Bioworks Holdings' Cost of Revenue fell 18.12% to $8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.1 million, marking a year-over-year increase of 9.97%. This contributed to the annual value of $38.5 million for FY2024, which is 17.14% down from last year.
  • Per Ginkgo Bioworks Holdings' latest filing, its Cost of Revenue stood at $8.2 million for Q3 2025, which was down 13.40% from $9.4 million recorded in Q2 2025.
  • In the past 5 years, Ginkgo Bioworks Holdings' Cost of Revenue registered a high of $81.8 million during Q4 2021, and its lowest value of -$870,000 during Q4 2023.
  • In the last 3 years, Ginkgo Bioworks Holdings' Cost of Revenue had a median value of $9.2 million in 2024 and averaged $10.1 million.
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' Cost of Revenue skyrocketed by 1,045.62% in 2021, and later tumbled by 109.09% in 2023.
  • Quarterly analysis of 5 years shows Ginkgo Bioworks Holdings' Cost of Revenue stood at $81.8 million in 2021, then slumped by 88.29% to $9.6 million in 2022, then crashed by 109.09% to -$870,000 in 2023, then surged by 968.16% to $7.6 million in 2024, then dropped by 18.12% to $8.2 million in 2025.
  • Its Cost of Revenue stands at $8.2 million for Q3 2025, versus $9.4 million for Q2 2025 and $8.0 million for Q1 2025.